Causes of delayed presentation of retinoblastoma

A single centre study

https://doi.org/10.53730/ijhs.v7nS1.14717

Authors

  • Muhammad Irfan Wazir District Eye Specialist DHQ TH Bannu
  • Samina Karim Assistant Professor, HMC, Hayatabad Peshawar

Keywords:

Retinoblastoma, Cancer, Malignant tumor, Leucocoria

Abstract

Aim: The aim of the study was to determine the Causes of Delayed Presentation of Retinoblastoma. Materials and methods: This study was carried out at the department of ophthalmology DHQ TH Bannu from January 2022 to January 2023. In this research newly recruited patients were included who were receiving therapy for retinoblastoma during that time. For this study, parents of patients who came into the hospital were gathered.  A form via the patient's information was noted. First symptom, duration after onset of initial symptom, gender, age at first visit. The data analysis software used was SPSS version 20. The importance of each factor was determined using the Pearson Chi Square test. Results A total of 80 participants were include in the study. 52(65%) patients had delayed presentation, 57(71%) had delayed referral presentation and 65(81%) had advanced diseases at the time of presentation. Various factors involved in the delay presentation. These factors are, living in a remote region; financial hardship; social pressure; knowledge of the severity of the illness; lack of transportation; Fear of enucleation and looking for alternative medications or non-medical treatments. Each factor significance was calculated through chi-square test. 

Downloads

Download data is not yet available.

References

Pizzo PA, Pop lack DG.Principals practice of pediatric oncology, 4th ed. Lippincott-Raven: Philadelphia, 2001: 828-846.

Kivelä T. The epidemiological challenge of the most frequent eye cancer: Retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009; 93: 1129-1131.

Shields JA, Shields CL.Management of retinoblastoma. In: Shields JA, Shields CL. Intraocular Tumors. An Atlas and Textbook. Philadelphia, PA: Lippincott Williams Wilkins; 2008: p. 334-351.

Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006; 17 (3):228–234.

Adhi MI, Kashif S, Muhammed K, Siyal N. Clinical pattern of Retinoblastoma in Pakistani population: Review of 403 eyes in 295 patients. J Pak Med Assoc. 2018; 68 (3): 376-380. PMID: 29540871.

Yousef YA, Soliman SE, Astudillo PPP, Durairaj P, Dimaras H, Chan HSL, et al. Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review. JAMA Ophthalmol. 2016; 134 (5): 584-591.

Meel R, Radhakrishnan V, Bakhshi S. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012; 33(2): 80-88.

MacCarthy A, Birch J, Draper G, Hungerford J, Kingston J, Kroll M, et al. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol. 2009; 93 (1): 38-39.

Temming P, Lohmann D, Bornfeld N, Sauerwein W, Goericke S, Eggert A. Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. KlinischePadiatrie. 2012; 224 (6): 339-347.

Bowman R, Mafwiri M, Luthert P, Luande J, Wood M. Outcome of retinoblastoma in east Africa. PediatrBlood Cancer, 2008; 50 (1): 160-162.

Kivelä T. 200 years of success initiated by James Wardrop’s 1809 monograph on retinoblastoma. Acta Ophthalmologica. 2009; 87 (8): 810-812.

S. E.Soliman, W. Eldomiaty, M.B. Goweida, A. Dowidar, Clinical Presentation of Retinoblastoma in Alexandria: A step towards earlier diagnosis, Saudi J Ophthalmol. 2017.

Khurram D, Zaheer N, Sharif N. Effects of Primary Chemotherapy, Radiotherapy plus Local Treatments on Regression Patterns of Posterior Pole Retinoblastoma. Pak J Ophthalmol. 2011; 27 (4): 214-219.

Bukhari S, Aziz-ur-Rehman BI, Qidwai U.Presentation pattern of retinoblastoma. Pak J Ophthalmol. 2011; 27 (3): 142-145.

Islam F, Zafar SN, Siddiqui SN, Khan A. Clinical course of retinoblastoma. J Coll Physician Surge Pak. 2013; 23 (8): 566-569.

Khan SJ, Inayat N. Paediatric retinoblastoma presentation in a regional cancer centre in Pakistan. J Cancer Allied Spec. 2017; 3 (2).

Ashraf T, Ahmed S, Tanveer S. Factors associated with delay in cancer diagnosis and treatment in children, a study from northern Pakistan. Professional Med J. 2019; 26: 1156-1161.

Mushtaq A, Khan AA, Sadiq MAA, Qayyum S, Khan MR, Raza A. Retinoblastoma treatment outcomes in Pakistan. Professional Med J. 2020; 27(11): 2499-2503.

Khaqan HA, Imtiaz U, Ateeq-ur-Rehman, Rasheed U. Experience of selective intra-arterial chemotherapy for Retinoblastoma. J Pak Med Assoc. 2020; 70 (1):178-182.

Shehla Z, Nasir I, Atif R. Comprehensive case study from Pakistan Primary Health Care Systems (PRIMASYS).

Sharma DB, Gupta V, Saxena K, Shah UM, Singh US. Role of Faith healers: A barrier or a support system to medical care- a cross sectional study. J Family Med Prim Care, 2020; 9 (8):4298-430

Singh U, Katoch D, Kaur S, Dogra MR, Bansal D, Kapoor R. Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India, Ocul OncolPathol. 2017; 4 (1): 23-32.

Published

27-03-2023

How to Cite

Wazir, M. I., & Karim, S. (2023). Causes of delayed presentation of retinoblastoma: A single centre study. International Journal of Health Sciences, 7(S1), 3207–3213. https://doi.org/10.53730/ijhs.v7nS1.14717

Issue

Section

Peer Review Articles

Most read articles by the same author(s)